Caspases are a family of cysteine proteases expressed as inactive zymogens in virtually all animal cells. These enzymes play a central role in most cell death pathways leading to apoptosis but growing evidences implicate caspases also in nonapoptotic functions. Several of these enzymes, activated in molecular platforms referred to as inflammasomes, play a role in innate immune response by processing some of the cytokines involved in inflammatory response. Caspases are requested for terminal differentiation of specific cell types, whether this differentiation process leads to enucleation or not. These enzymes play also a role in T and B lymphocyte proliferation and, in some circumstances, appear to be cytoprotective rather than cytotoxic. These pleiotropic functions implicate caspases in the control of life and death but the fine regulation of their dual effect remains poorly understood. The nonapoptotic functions of caspases implicate that cells can restrict the proteolytic activity of these enzymes to selected substrates. Deregulation of the pathways in which caspases exert these nonapoptotic functions is suspected to play a role in the pathophysiology of several human diseases.
Introduction
A total of 12 cysteine proteases known as caspases have been identified in mammals: caspase-1 to -10, caspase-12 and caspase-14. The protein initially named caspase-13 was later found to represent a bovine homolog of caspase-4, and caspase-11 is most likely the murine homolog of human caspase-4 and -5. These enzymes, which are expressed in virtually all animal cells, play an essential role in many forms of cell death by apoptosis (Nicholson and Thornberry, 1997) . They are synthesized as inactive proenzymes (procaspases) and can be classified into two main groups according to the length of their N-terminal prodomain.
Procaspases with a short prodomain (procaspase-3, -6 and -7) exist in the cells as dimers that require proteolysis at internal aspartate residues to generate two large and two small subunits. Active enzymes result from heterodimerization of these subunits, thus include two active sites. These caspases are the main effectors of apoptotic cell death by cleaving cellular substrates, either a downstream procaspase or other cellular proteins, on the carboxy-terminal side of an aspartate residue. Other procaspases such as procaspase-8, -9 and -10 are characterized by their long prodomain. They exist in living cells as monomers and require dimerization or oligomerization for activation that can occur in the absence of any proteolytic cleavage (Salvesen and Abrams, 2004) . These enzymes are usually the initiators of a caspase cascade although the main functions of some of them do not relate to apoptosis.
Two main pathways of caspase activation leading to apoptotic cell death have been described. Schematically, the intrinsic pathway involves sentinel proteins of the Bcl-2 family, also known as 'BH3-only proteins' that, in response to a cellular damage, migrate to the mitochondria to either antagonize antiapoptotic proteins of the Bcl-2 family or activate multi-domain proapoptotic proteins Bax and Bak (Marsden and Strasser, 2003) . In turn, the external membrane of the mitochondria is permeabilized and soluble molecules are released from the mitochondrial intermembrane space into the cytosol. These molecules include cytochrome c that, in the presence of ATP, triggers oligomerization of a platform protein named Apaf-1 that recruits and activates caspase-9. Other soluble molecules are simultaneously released from the mitochondria to antagonize the inhibitory functions of (inhibitor of apoptosis proteins) (IAPs) on caspases such as caspase-9, -3 and -7 (Acehan et al., 2002; Hill et al., 2004) . A caspase cascade is activated in the cytosol, leading to the limited proteolytic cleavage of intracellular, structural and regulatory proteins, which leads to membrane blebbing, chromatin condensation and nuclear DNA fragmentation. The extrinsic pathway starts at the level of plasma membrane by engagement of transmembrane death receptors such as Fas/CD95, tumor necrosis factor receptor 1 (TNF-R1) and TNF-related apoptosis-inducing ligand (TRAIL) receptors. Multiprotein complexes are formed in which caspase-8 and -10 are recruited by the adaptor molecule Fas-associated death domain protein (FADD) and activated. In turn, these enzymes either directly activate the caspase cascade or connect the extrinsic to the intrinsic pathway through cleavage of the sentinel, BH3-only protein Bid (Figure 1) .
Thus, in the setting of apoptosis, the roles of caspases are: (i) to initiate (initiator caspase-8, -9) the caspase cascade and (ii) to execute (effector caspase-3, -6, -7) the apoptotic program through cleavage of plenty of vital proteins. Their activation is under control of the balance between pro-and antiapoptotic proteins of the Bcl-2 family, heat-shock proteins and IAPs . Caspase-2 could play a role in both initiation and execution phases of apoptotic cell death (Droin et al., 2001; Lassus et al., 2002) . Target proteins cleaved by caspases in cells undergoing apoptosis are either inactivated by the cleavage such as antiapoptotic proteins (Bcl-2 and Bcl-xL), actin, lamin, kinases (Akt, Raf-1 and MEK) and transcription factors (GATA-1 and STAT1) or become functional to exert a discrete function in propagation of cell death including kinases (MEKK1, PKC, PAK2, MST1), proapoptotic proteins (Bid, Bad) or signalling molecules for transcription factors (IkBa) . However, apoptosis can occur in the absence of caspase activation (Garrido and Kroemer, 2004) , whereas caspase activation does not systematically trigger cell death. Recent studies have pointed out the role of caspases in nonapoptotic pathways, including inflammatory response, immune cell proliferation, differentiation of various cell types and others. This review will focus on these nonlethal functions of caspases, summarized in Table 1 .
A role for caspases in innate immunity and inflammatory response A subfamily of caspases including human caspase-1, -4 and -5 and mouse caspase-11 and -12, referred to as the 'caspase-1 subfamily', has been identified in vertebrates. Some of these caspases could be involved in apoptotic pathways, for example, caspase-1 could play a role in neuronal cell death, but their main function is the regulation of inflammatory processes. Caspase-1 was originally identified as interleukin-1b (IL-1b)-converting enzyme, the enzyme responsible for the processing of proIL-1b into active IL-1b in macrophages (Thornberry et al., 1992) . The requirement for caspase-1 in IL-1b maturation was confirmed by generation of mice deficient in caspase-1, which are resistant to the lethal effect of endotoxins (Kuida et al., 1995; Li et al., 1995) . Analysis of these mice indicated that caspase-1 was required for migration of epidermal dendritic cells (Langerhans cells) from epidermis to draining lymph nodes in cutaneous immune response, which was probably a consequence of defective IL-1b activation (Antonopoulos et al., 2001) . Caspase-1 activates another member of the IL-1 cytokine superfamily, IL-18, also known as interferon-g-inducing factor, whereas the cleavage of proIL-18 by caspase-3 generates inactive fragments (Gracie et al., 2003) . Thus, caspase-1 contributes to inflammation by triggering the proteolysis and maturation of prointerleukins. Figure 1 Schematic representation of the main caspase-involving apoptotic pathways. Cellular damage usually activate the so-called 'intrinsic pathway' that involves sentinel proteins of the Bcl-2 family (BH3-only proteins). These sentinels modify the equilibrium between antiapoptotic (AA) and multidomain proapoptotic (MPA) proteins of the Bcl-2 family, thus induce permeabilization of the mitochondrial external membrane (M ¼ mitochondria). Cytochrome c is released in the cytosol, induces the formation of the apoptosome in which the initiator caspase-9 is activated and activates the caspase cascade. The extrinsic pathway involves the death receptors (DR) at the plasma membrane level. In response to their specific ligand (DR-Ligand), these trimeric receptors recruit the adapter molecule FADD and either procaspase-8 or À10 in the death-inducing signaling complex (DISC). These enzymes either directly (T lymphocytes) or indirectly through cleavage of the BH3-only protein Bid (hepatocytes) activate the caspase cascade
Nonlethal roles for caspases S Launay et al
Human caspase-4 and -5 could arise from the gene duplication of a caspase-11-like ancestral gene. Like murine caspase-11, expression of caspase-5 is inducible by lipopolysaccharides (LPS), which is not the case for caspase-1 (Wang et al., 1998; Lin et al., 2000) . Caspase-5 is involved in IL-1b maturation by interacting with caspase-1 in multiprotein complexes called inflammasomes in which caspase-1 is activated . According to caspase-4, its transcription is induced by interferons but little is known on its functional role (Ahn et al., 2002 ). An effector caspase, caspase-3, could process another prointerleukin in CD8-positive lymphocytes, namely prointerleukin-16, to release a biologically active IL-16, suggesting redundancies in the functions of proinflammatory and proapoptotic enzymes of the caspase family (Zhang et al., 1998b) .
Inflammatory caspases belong to the group of initiator caspases that exist in the cells as inactive monomers and require dimerization or oligomerization to assume an active conformation, with or without proteolytic cleavage. Dimerization or oligomerization occur in specialized multimeric platforms that recruit multiple procaspase molecules into close proximity to provoke their activation. Several platforms in which caspase-1 could be activated have now been described and named inflammasomes. A first one involves an interaction between the adaptor protein Ipaf and caspase-1 (Damiano et al., 2001; Geddes et al., 2001; Poyet et al., 2001) . Caspase-1 is also activated into NALP inflammasomes, which are multiprotein complexes involving proteins of the NALP family. NALP1, the first identified activating platform in this group, recruits caspase-5 and, through the adaptor protein ASC, caspase-1 (Martinon et al., 2002) . Two other activating platforms of the NALP family, named NALP2 and NALP3, can recruit ASC and activate caspase-1 in a multiprotein complex in which a protein designated Cardinal is also recruited, whereas caspase-5 is not (Agostini et al., 2004) . Caspase-1 can be . These mutations could cause high states of activation of one or several inflammasomes, resulting in local or systemic inflammation. In patients with Muckle-Wells syndrome or chronic infantile cutaneous and articular syndrome, administration of an IL-1 inhibitor dramatically attenuates the disease symptoms . Caspase-1 was recently proposed to contribute to inflammation by activating a distinct pathway in B cells. This pathway involves an interaction of the caspaserecruitment domain (CARD) of procaspase-1 with the CARD-containing kinase receptor-induced protein RIP2, which, in turn, recruits the IkB kinase (IKK) complex to activate nuclear factor of the k-enhancer B (NF-kB) and p38 mitogen-activated protein kinase (MAPK) (Lamkanfi et al., 2004) . Taken together, these data demonstrate that some caspases play a critical role in the regulation of multiple proinflammatory pathways by activating interleukins and intracellular signaling pathways.
Caspase-12 was initially reported to play a role in apoptosis induced by endoplasmic reticulum stress in rodent cells but is phylogenetically related to inflammatory caspases (Nakagawa et al., 2000) . In humans, a single nucleotide polymorphism at amino-acid position 125 in caspase-12 results in the synthesis of either a truncated (TGA stop codon) or a full-length (CGA read-through codon) proenzyme. The full-length allele was identified only in populations of African descent (about 20% of them) and appeared to be increased in African American individuals with severe sepsis. This full-length caspase-12 reduced the magnitude of endotoxin-induced immune response, acting as a dominantnegative regulator of the IL-1 and NF-kB pathways (Saleh et al., 2004) .
The link between caspases and innate immunity extends to Drosophila. A fly screen to identify mutants defective in innate immunity revealed that a loss-offunction mutation in the gene encoding the caspase Dredd blocked the expression of all genes that code for peptides with antibacterial activity, thus rendering flies highly susceptible when challenged with Gram-negative bacteria (Leulier et al., 2000) .
A role for caspases in adaptive immunity by controling lymphocyte proliferation
Defects in Fas-mediated apoptosis, due to heterozygous mutations in Fas, its ligand or caspase-10 were shown to account for the autoimmune lymphoproliferative syndrome (ALPS), which is also known as the CanaleSmith syndrome (Rieux-Laucat et al., 2003) . ALPS is characterized by the accumulation of a polyclonal population of T cells called double-negative T cells that fail to produce growth and survival factors such as interleukin-2. This population appears to originate from antigen-exposed T cells that downregulate the expression of CD8 and fail to undergo apoptosis. Analysis of patients with atypical ALPS identified a homozygous caspase-8 mutation leading to inactivation of the enzyme. Interestingly, this mutation induced defects in the activation and proliferation of T lymphocytes, B lymphocytes and natural killer cells, for example, caspase-8-deficient T cells had a defect in the production of IL-2 (Chun et al., 2002) . This observation explained previous reports suggesting that caspase inhibitors could interfere with T-cell proliferation and that Fas-ligand could stimulate the proliferation and IL-2 secretion in response to a suboptimal dose of anti-CD3 antibody (Alam et al., 1999; Kennedy et al., 1999; Boissonnas et al., 2002) . As indicated above, mice in which casp-8 gene has been disrupted demonstrate embryonic lethality due to impaired heart muscle development and hematopoietic progenitor deficiency (Varfolomeev et al., 1998) . Postnatal survival in humans may be due to the compensatory function of caspase-10, the closest paralog of caspase-8 that exists in humans but has no known ortholog in mice. Targeted caspase-8 mutation restricted to the T-cell lineage confirmed the role of caspase-8 in T-cell activation and led to immunodeficiency, for example, affected the ability of T cells to clear lymphocytic choriomeningitis virus (Salmena et al., 2003) . The mechanism whereby caspase-8 deletion affects activation-induced T-cell expansion remains unclear, although a role in cell response to cytokines such as IL-2 has been suspected. Caspase activity during T-cell proliferation was shown to result in the cleavage of the kinase Wee1 (Alam et al., 1999) . This cleavage prevents phosphorylation of the cell cycle-regulating kinase Cdc2, thereby promoting kinase activity of Cdc2 and progression through the cell cycle (Castedo et al., 2002) . Since conditional ablation of caspase-8 in bone-marrow cells was observed also to compromise macrophage proliferation, caspase-8 appears to play an essential role in immune system homeostasis that does not depend on its proapoptotic functions (Kang et al., 2004) .
The cytoplasmic adapter molecule FADD, which recruits caspase-8 in the death-inducing signaling complexes, was shown also to play a role in T-cell activation and proliferation. Transgenic mice expressing a dominant negative mutant of FADD demonstrate defective T-cell activation-induced proliferation through the T-cell receptor and CD28 and fail to mount an antigen-specific immune response when infected with the lymphocytic choriomeningitis virus (Newton et al., 1998; Walsh et al., 1998; Zhang et al., 1998a) . Thus, Tcell survival under conditions of proliferation could require the FADD-mediated activation of caspase-8. In the absence of a functional FADD-caspase-8 pathway, T cells may die during the progression of the cell cycle through a necrosis-like death mechanism. In the presence of a functional FADD-caspase-8 pathway, these T cells may eventually die by apoptosis. Either way, T cells are prevented from proliferating uncontrollably (Beisner et al., 2003; Salmena et al., 2003) . The role of c-FLIP L , the long isoform of c-FLIP that resembles caspase-8 but lacks its enzymatic activity, in T-cell growth is more confusing as enforced expression of this protein in the T-cell compartment either increases (Lens et al., 2002) or decreases (Tai et al., 2004) T-cell receptor-triggered proliferation. Anyway, whereas inflammatory caspases play a central role in innate immunity, caspase-8, in association with FADD, is crucial to adaptive immunity.
In B cells, caspases also regulate cell cycle progression. Mice deficient in caspase-3 have an increased number of splenic B cells that show normal apoptosis but enhanced proliferation, both in vivo and after mitogenic stimulation in vitro (Woo et al., 2003) . Caspase-3 was proposed to cleave the cyclin-dependent kinase inhibitor (CDKI) p21
, thus removing its C-terminus that interacts with proliferating cell nuclear antigen (PCNA) to promote proliferation. Interestingly, the expression of p27 Kip1 , another CDKI that is a potential target for caspase-3 (Eymin et al., 1999b) , remains unchanged in mitogen-activated B cells, which enforces the idea that substrate specificity is essential for nonapoptotic functions of caspases. In contrast to this negative effect of caspase-3 on B-cell proliferation, caspase-6 was proposed to mediate entry of quiescent B cells into G 1 phase of the cell cycle upon stimulation. One of the selective targets of caspase-6 in this process could be the transcriptional suppressor special AT-rich sequence-binding protein 1 (Olson et al., 2003) . Thus, B-cell proliferation analysis points out a dual effect of caspases in the same process. Caspases may serve as additional checkpoints in the control of cell cycle in T and B cells by specific cleavage of negative or positive regulators of the cell cycle machinery.
Caspases and differentiation with enucleation
The involvement of caspases in cell differentiation was initially suspected in those whose terminal differentiation is associated with enucleation. Erythroblasts, keratinocytes and lens epithelial cells lose their nucleus and other subcellular organelles during their terminal differentiation but continue to be metabolically active.
Erythropoiesis is promoted by the hormone erythropoietin (Epo) and involves the sequential formation in the bone marrow of proerythroblasts and basophilic, polychromatophilic and orthochromatic erythroblasts. These latter cells extrude their nucleus and enter the circulation as mature red blood cells. The terminal differentiation of erythroid cells exhibits some similarities with apoptosis such as chromatin condensation and the degradation of nuclear components (Morioka et al., 1998) . The process of enucleation itself could involve p53 in erythroid cells (Peller et al., 2003) and DNase IIa from central macrophages in the erythroblastic island (Kawane et al., 2001; Krieser et al., 2002) . A transient activation of several effector caspases is required for Epo-induced erythroid differentiation in both humans and mice. However, this transient caspase activation may not account for enucleation as it occurs at earlier steps of red blood cell formation (Zermati et al., 2001; Kolbus et al., 2002; Carlile et al., 2004) . Accorcdingly, the large spectrum caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (z-VAD.fmk) arrests the in vitro maturation of erythroid progenitors before nucleus and chromatin condensation (Zermati et al., 2001) . In addition, ablation of caspase-3 through the use of small interfering RNAs blocks erythropoiesis at the transition between pro-and basophilic erythroblasts (Carlile et al., 2004) . Caspases are probably activated through a mitochondria-dependent pathway similar to that identified in various forms of apoptosis (Zermati et al., 2001; Kolbus et al., 2002) and cleave proteins involved in nucleus integrity (lamin B) and chromatin condensation (acinus) (Zermati et al., 2001) . Interestingly, caspase activation in erythroid cells undergoing differentiation is negatively regulated by the Raf-1 kinase, which prevents premature differentiation of actively proliferating precursors (Kolbus et al., 2002) .
The transcription factor GATA-1 plays a major role in the control of erythroid differentiation, for example, it is required for Epo-mediated upregulation of the antiapoptotic protein Bcl-xL (Gregory et al., 1999) . GATA-1 is cleaved by caspases in erythroid cells undergoing apoptosis under Epo deprivation or death receptor stimulation (De Maria et al., 1999) , but remains uncleaved in erythroid cells undergoing terminal differentiation (Zermati et al., 2001) . The differential cleavage of GATA-1 by caspases in erythroid cells undergoing differentiation versus apoptosis indicates that the ability of caspases to cleave their cellular protein targets depends on the cellular context.
Targeted disruption of the casp-8 gene results in embryonic lethality with congested accumulation of erythrocytes in mice (Varfolomeev et al., 1998) . The phenotype of mice in which the gene encoding the adaptor molecule FADD is disrupted resembles that of caspase-8 À/À animals (Yeh et al., 1998; Zhang et al., 1998a) . FADD and caspase-8 could play a role in the negative regulation of erythropoiesis through a negative feedback loop where mature erythroblasts, which express Fas-ligand, might exert a cytotoxic effect on immature erythroblasts expressing the death receptor Fas within the erythroblastic island (De Maria et al., 1999) . In Fas-stimulated immature erythroblasts, the transcription factor GATA-1 is cleaved by activated caspases, which impairs erythroid differentiation or leads to apoptosis, depending on Epo concentration in the environment. Thus, caspase-mediated cleavage of GATA-1 represents a negative control mechanism that regulates the total red cell mass (De Maria et al., 1999) .
Another transcription factor, the basic helix-loophelix protein SCL/Tal-1, was reported to be cleaved by caspases when activated in erythroid cells under stimulation of death receptors or Epo deprivation. Caspase-mediated cleavage of SCL/Tal1 was proposed to amplify caspase activation, which leads to GATA-1 cleavage in Epo-deprived or death receptor-stimulated immature erythroid cells (Zeuner et al., 2003) .
Myelodysplastic syndromes are a heterogeneous group of disorders of hematopoietic stem cells characterized by a hypercellular bone marrow with morphological features of dysplasia and peripheral blood cytopenias with anemia dominating the clinical picture. At early stages of development of the disease, a high rate of apoptosis in the bone marrow hematopoietic cells is responsible for ineffective erythropoiesis (Raza et al., 1995; Tehranchi et al., 2003; Testa, 2004) and several studies indicate that the activation of the Fas-ligand/Fas pathway plays an important role in this pathogenic event (Gersuk et al., 1996; Bouscary et al., 1997; Claessens et al., 2002) . Thus, exacerbation of the physiologic mechanisms of Fas-mediated control of erythropoiesis, which functions even in the presence of high concentrations of Epo, may account for early elimination of erythroid precursors and anemia in these syndromes. Accordingly, lentivirus-mediated transduction of a dominant-negative FADD construct in hematopoietic progenitors from patients with early stage myelodysplasia prevents caspase-8 activation in erythroid cells cultured in vitro, thus restoring erythropoiesis (Claessens et al., 2005) . In some of these myelodysplastic syndromes, growth factors such as granulocyte colony-stimulating factor were reported to inhibit Fas-induced caspase activation by inhibiting the mitochondrial pathway to cell death (Schmidt-Mende et al., 2001; Tehranchi et al., 2003) . However, how this granulocyte-specific growth factor interferes with erythropoiesis remains unexplained. Amplification of physiological caspase activation associated with erythroid differentiation may also account for apoptosis of megaloblastic erythroblasts that appears upon folate or cobalamine deficiency, as well as erythroblasts from patients with b-thalassemia, parvovirus B19 infection and congenital aplastic anemia. Activation of caspases through the death receptor pathway could account also for anemia observed in diseases such as multiple myeloma and rheumatoid arthritis (Testa, 2004) .
Another differentiation process with enucleation in which caspases play a role is lens fiber differentiation. Primary fibers develop from lens epithelial cells that form the posterior, half of early lens vesicle. These primary fibers constitute the core at the centre of the lens whereas secondary fibers develop from epithelial cells at the equatorial region of the lens (Goss, 1978) . As each fiber forms, the nucleus and other organelles are lost, which is of fundamental importance to the function of the mature lens since it leads to the formation of a transparent region at its center. Disturbances in this process lead to congenital cataracts, due to disordered fiber cell packing and scattering of light by the organelles (Dahm et al., 1998) . Transgenic mice overexpressing the antiapoptotic Bcl-2 protein in their lenses demonstrate disturbances of lens development, including the persistence of intact or fragmented nuclei (Fromm and Overbeek, 1997) . In an explant culture of anterior epithelium from rat lens, in which epithelial cells differentiate into fibers under exposure to bFGF (Fibroblast Growth Factor) and insulin, the formation of lentoid bodies is associated with poly(ADP-ribose) polymerase (PARP) cleavage and nuclear DNA fragmentation and is completely prevented by the caspase inhibitor z-VAD-fmk and some more specific caspase inhibitors (Ishizaki et al., 1998; Wride et al., 1999; Sanders and Parker, 2002) . Interestingly, caspase-6 activation was detected in lens from rat embryos during the period when organelles are eliminated, 2-3 days before enucleation (Foley et al., 2004) . However, caspase 6 À/À mice do not demonstrate any lens alteration, which suggests that other caspases are involved in lens differentiation. Whether caspases are directly responsible for organelle loss and enucleation or play a role in earlier stages of the differentiation process remains to be clarified.
A third cell type in which terminal differentiation is associated with enucleation and caspase activation is the epidermal keratinocyte. Caspases are activated during human keratinocyte differentiation in organotypic cultures and this activation has been suggested to be required for the normal loss of the nucleus (Weil et al., 1999) . In cultured keratinocytes undergoing differentiation, caspase activation is associated with a gradual decrease in mitochondrial membrane potential and a progressive release of cytochrome c from some mitochondria (Allombert-Blaise et al., 2003). Caspase-14, which shows a restrictive tissue expression mainly confined to the epidermal keratinocyte, was suggested to be the main caspase involved in this differentiation process (Eckhart et al., 2000; Lippens et al., 2000; Chien et al., 2002; Rendl et al., 2002) . Interestingly, a recent study demonstrated that casp-3 gene was a transcriptional target of Notch1, a transmembrane receptor involved in keratinocyte differentiation. Elevated caspase-3 expression and activity were shown to partially account for the commitment of embryonic keratinocytes to terminal differentiation, which explains the increased thickness and the reduced expression of terminal differentiation markers observed in caspase-3 À/À mice epidermis (Okuyama et al., 2004) .
Although terminal differentiation of red blood cells, lens fibers and keratinocytes is characterized by enucleation, most studies in these cell types suggest that caspase activation is not directly involved in the enucleation process and is required at earlier steps of the differentiation pathways. In all these cells, activated caspase levels are not sufficient to trigger apoptosis and result in the more selective targeting of substrates such as lamin B in erythroblasts (Zermati et al., 2001 ) and protein kinase Cd in keratinocytes (Okuyama et al., 2004) . In addition, the caspase targets may vary, depending on the differentiation pathway, as PARP is cleaved during lens fiber differentiation while remaining uncleaved in erythroblasts and keratinocytes.
Caspases and differentiation without enucleation
Caspase activity has been shown to be required also for the differentiation of specific nucleated cell types. One of the best-studied example is skeletal myoblast differentiation in which activation of caspases was initially related to the death of a fraction of cells that is usually observed in in vitro models of myoblast cultures . Actually, caspase-3-null mice that survive to early perinatal life are strikingly smaller relative to their wild-type littermates, with a reduction in total skeletal muscle mass. Primary myoblast cultures demonstrated that casp-3 gene deletion altered the in vitro formation of myotubes and the appearance of several differentiation-specific proteins without modifying the rate of apoptosis associated with the differentiation process (Fernando et al., 2002) . Interestingly, expression of active caspase-3 into a subconfluent population of myoblasts initiated the differentiation program without inducing cell death. The serine/threonine kinase MST1 (for Mammalial Steril Twenty-like kinase) appears to mediate caspase-3 function in muscle differentiation as it is activated through caspase-3-mediated removal of its C-terminal negative regulatory domain in muscle cells undergoing differentiation and active MST1 rescues myogenesis in caspase-3 À/À mice (Fernando et al., 2002) . Raf signaling could negatively regulate caspase-3 activity in skeletal myoblasts undergoing differentiation, as observed in erythropoiesis (DeChant et al., 2002) . Based on the pharmacological manipulation of caspases by permeant inhibitory peptides, caspase-1 has also be involved in rat myoblast fusion and this effect was related to calpastatin degradation (Barnoy and Kosower, 2003) .
In Drosophila melanogaster, caspases are involved in sperm differentiation and possibly in oogenesis. In Drosophila males, several apoptotic proteins play a role in spermatid individualization, including multiple caspases, dFADD, ARK (the Drosophila homolog of Apaf-1) and one of the two cytochrome c genes, cyt-c-d (Arama et al., 2003; Huh et al., 2004b ). An apoptosomelike complex could be assembled to activate caspases and remove the bulk cytoplasm from spermatids (Arama et al., 2003) . Interestingly, caspase activation during spermatid differentiation could be the main function of cytochrome-c-d in this animal. Organelles and in particular sperm nucleus must be protected against the potentially lethal activity of caspases activated during the differentiation process. dBruce, a Drosophila IAP that is homolog to human Apollon and encodes a E2 ubiquitin-conjugating enzyme, may exert this function in specific cell compartments (Arama et al., 2003) .
In the Drosophila ovary, one germ cell in an egg chamber becomes an oocyte, whereas the 15 sister germline cells develop into nurse cells that are linked to the oocyte by cytoplasmic bridges. These so-called 'ring canals' are used by nurse cells to transfer RNA and proteins to the oocyte. This event requires actin-and myosin-based contraction of the nurse cells that subsequently degenerate and die by apoptosis. Loss of function of dcp-1 gene, which encodes a caspase similar in sequence to mammalian caspase-3 and -6, was proposed to inhibit the transfer of cytoplasm from nurse cells to developing ovocytes, which causes sterility. Thus, caspases could be involved in cytoskeletal and nuclear events in nurse cells (McCall and Steller, 1998) . However, several phenotypes attributed to the loss of dcp-1 are due to the disruption of CG3941 gene or the combined disruption of both genes, as dcp1 is located in an intron of CG3941 gene and P element alleles associated with the sterile phenotype also disrupt CG3941 (Corrections and Clarifications, 2004) .
Caspase activation has been involved in thrombopoietin-induced megakaryocyte differentiation and proplatelet formation. As observed in erythropoiesis, an agonist anti-Fas antibody inhibits megakaryocytopoiesis in vitro. This effect is credited to the caspase-induced cleavage of transcription factors GATA-1 and NF-E2, suggesting a Fas-mediated negative regulation of megakaryocytopoiesis (De Maria et al., 1999) . Thrombopoietin is the ligand of Mpl receptor whose engagement on megakaryocytes stimulates proliferation and promotes polyploidization and maturation. Interestingly, the serine/threonine kinase MST1 was shown to be activated by Mpl-ligand and to participate in the Mplligand-induced signalling pathways that potentiate polyploidization and megakaryocyte differentiation (Sun and Ravid, 1999) . Whether caspase-mediated cleavage of MST1, identified in apoptotic B lymphocyte (Graves et al., 1998) and involved in myoblast differentiation (Fernando et al., 2002) , is required for MST1 function in megakaryocytopoiesis has to be explored.
Another function of caspases in megakaryocytopoiesis is proplatelet formation. Platelets are enucleated cells formed by the fragmentation of the mature megakaryocyte cytoplasm and arise from the development of thin, long cytoplasmic extensions called proplatelets. A localized activation of caspase-3 mediated by cytochrome c released from the mitochondria and prevented by Bcl-2 overexpression actively participates in the formation of proplatelets (De Botton et al., 2002) . Moreover, caspases also play a role in platelet activation. Treatment with z-VAD.fmk, a pancaspase inhibitor, significantly decreases ADP-induced platelet aggregation (Cohen et al., 2004) .
Differentiation-associated caspase activation is not always associated with phenotypic changes reproducing those observed in cells dying by apoptosis. For example, several caspases are activated in peripheral blood monocytes undergoing differentiation into macrophages when cultured in the presence of M-CSF, whereas no caspase activation can be detected when these peripheral blood monocytes undergo differentiation into dendritic cells under exposure to GM-CSF and IL-4. Caspase activation in monocytes undergoing differentiation into macrophages involves the mitochondrial release of cytochrome c and leads to the cleavage of specific proteins such as acinus, whereas other well-characterized caspase targets such as PARP remain uncleaved. Overexpression of Bcl-2 and inhibition of caspases by z-VAD-fmk or the baculoviral inhibitory protein p35 inhibit the differentiation process (Sordet et al., 2002) . The role of caspases in the differentiation of monocytes into macrophages was recently confirmed by analysis of a mouse model in which the casp-8 gene could be conditionally disrupted by using the Cre/loxP recombination system. This model revealed several nonapoptotic functions of caspase-8, for example, casp-8 gene deletion in bone marrow cells prevented hematopoietic progenitors from forming myeloid and B-lymphoid colonies, both in vitro and in vivo. When casp-8 gene deletion was restricted to cells of the myelomonocytic lineage, the differentiation of monocytes into macrophages was arrested, whereas their differentiation into dendritic cells or granulocytes remained unaffected (Kang et al., 2004) . Of interest, homozygous deletion of bid gene involved in death receptor signal amplification, induces a fatal, clonal malignancy closely resembling chronic myelomonocytic leukemia (Zinkel et al., 2003) . This latter observation suggests a connection between Bid protein and caspase-8 activation in monocytes undergoing differentiation into macrophages.
Caspase activation has also been tightly linked to differentiation of an osteoblastic cell line exposed to the bone morphogenetic protein BMP-4 (Mogi and Togari, 2003) , to terminal differentiation of a colon carcinoma cell line exposed to butyrate (Cai et al., 2004) and to postnatal development of rat cerebellum (Oomman et al., 2004) .
A role for caspases in preventing cell death
Based on the assumption that apoptotic death of mammalian cells usually depends on caspase activation, pharmacological inhibition of these enzymes may be beneficial in diseases in which excessive apoptosis plays a pathophysiologic role. Actually, inhibition of caspases can paradoxically enhance cell death. This was clearly demonstrated by studying death receptor-mediated apoptosis, both in vitro and in vivo. Inhibition of caspases, either with z-VAD.fmk or by transfection of the poxvirus-derived caspase inhibitor CrmA that selectively inhibits caspase-8, prevents or delays deathreceptor-mediated apoptosis in most cell lines, yet sensitizes some of these cell lines to death-receptormediated necrosis (Vercammen et al., 1998; Luschen et al., 2000; Chan et al., 2003) . These deleterious effects of caspase inhibition have been confirmed in vivo by showing that pretreatment with z-VAD.fmk sensitizes mice to the lethal effect of human or mouse recombinant TNFa, resulting in hyperacute hemodynamic collapse. This latter effect probably involves mitochondrially generated reactive oxygen species and an increase in peroxidation of lipids (Cauwels et al., 2003) . Interestingly, caspase-mediated cleavage of target proteins such as p27
Kip1 (Eymin et al., 1999a) and Rb (Rincheval et al., 1999) can generate fragments that demonstrate a protective effect towards cell death. The death receptor-mediated caspase-independent death pathway involves the death domain of the adapter protein FADD and the serine/threonine kinase activity of the receptor-induced protein (RIP), whereas the transcription factor NF-kB is not activated (Vercammen et al., 1998; Fiers et al., 1999; Holler et al., 2000; Vonarbourg et al., 2002) . The connection between FADD/RIP and mitochondrial production of reactive oxygen species remains poorly understood, although a pivotal role for phospholipase A 2 has been suggested (Cauwels et al., 2003) . Whether a limited activation of caspase-8 in the DISC in the presence of FLIP L (Micheau et al., 2002) or a protease-independent function of caspase-8 (Hu et al., 2000) are involved in this process remains to be clarified.
By arresting apoptosis, caspase inhibitors could promote other forms of cell death, for example, caspase-8 inhibition was shown recently to promote autophagic cell death, a process involving the genes ATG7 and beclin 1 genes. Again, this molecular pathway involves the serine-threonine kinase RIP together with the Jun amino-terminal kinase (JNK) (Yu et al., 2004) . The suppression of necrotic and autophagic death by caspases in mammalian cells indicates that caspases regulate both apoptotic and nonapoptotic cell death pathways. Thus, caspase inhibition as a therapeutic goal could have the untoward effect of exacerbating cell death.
Another protective effect has been proposed recently for caspase-2, an enzyme whose role in apoptosis is still controversial. This protease was shown to be recruited to a platform named PIDD (p53-induced death domain) to form a large multiprotein complex involving the adaptor protein RAIDD. Spontaneous activation of caspase-2 by overexpression of PIDD is not sufficient to trigger cell death, although it sensitizes to genotoxic damage-induced cell death. It is suggested that caspase-2 in this setting may have nonapoptotic effects such as activation of the DNA repair machinery (Tinel and Tschopp, 2004) .
A protective effect of caspases has been described in human dendritic cells undergoing maturation under exposure to LPS, a pathway that could involve LPSinduced activation of extracellular receptor kinases (ERKs) and upregulation of c-FLIP L (Franchi et al., 2003) . Lastly, a dual role for the initiator caspase Dronc was recently identified during wing development of Drosophila. Dronc-mediated ectopic cell death in some cells is associated with the compensatory proliferation of other cells, a mechanism required to maintain tissue size and homeostasis (Huh et al., 2004a) .
A role for caspases in cell motility and migration
Caspases were suggested to be involved in the maintenance of cytoskeleton integrity. This assertion was based on the ability of the poorly specific pancaspase inhibitor benzyloxycarbonyl-L-aspartyl-[(2,6-dichlorobenzoyl)oxy] methane (z-Asp-CH 2 -DCB) to inhibit cell spreading on collagen-coated plates without affecting viability nor proliferation. A caspase-3-like activity (cleavage of a z-Asp-Glu-Val-Asp (DEVD)-containing peptide) was detected in adherent cells while remaining undetectable in cells in suspension. However, more specific caspase inhibitors failed to inhibit cell spreading in this model (Watanabe and Akaike, 1999) .
More recently, analysis of CD95-resistant tumor cell lines again suggested a role for caspases in cell migration. A significant number of these CD95-resistant tumor cell lines respondes to stimulation of CD95 by increased motility and invasiveness through Matrigelcoated membranes. Among the different pathways that account for these effects of CD95 engagement, one could involve caspase-8, downstream or in parallel to a transcriptional activation induced by activated NF-kB. Based on this study, it was suggested that CD95-ligand expressed at the surface of numerous tumor cell types could have tumorigenic effects through CD95 stimulation of tumor cells with caspase-8 activation facilitating their migration (Barnhart et al., 2004) . How these observations are connected to the frequent inactivating mutations in the proximal pathway of CD95-mediated apoptosis affecting CD95, FADD and caspase-10 remains to be explained (Shin et al., 2002) .
Conclusions
Caspase activation does not mean cell death but how caspases are implied in different cell processes without killing the cells remains poorly known. The nonapoptotic functions of caspases implicate the selective cleavage of specific target proteins to avoid the cell dismantle. Various mechanisms could account for this restricted cleavage, including post-translational modifications of caspases and substrates, subcellular compartmentalization of the proteases, protection of potential target proteins by scaffold molecules, activation of antiapoptotic factors and recruitment of antagonistic proteins at the level of caspase activation platforms (Figure 2) .
Post-translational modifications concern caspases themselves, for example, Akt-mediated phosphorylation of caspase-9 was proposed to decrease its activity (Cardone et al., 1998) . Adapter proteins such as FADD could also be modified, for example, a slower migrating form of FADD has been detected in T cells exposed to mitogenic stimulation, while not being observed in T cells undergoing death receptor-mediated cell death (O'Reilly et al., 2004) . Post-translational modifications could also concern caspase targets, for example, the phosphorylation of serine residues adjacent to the caspase-3 cleavage site of presenilin-2 could protect the protein from cleavage (Walter et al., 1999) . Whether such modifications of caspases or their targets account for the Raf-mediated regulation of erythroid and skeletal muscle differentiation remains to be explored (DeChant et al., 2002; Kolbus et al., 2002) . A model in which RasGAP functions as a sensor of caspase activity to determine whether or not a cell should survive has been proposed. According to this model, a limited activation of caspases, for example, in response to a limited stress, leads to the partial cleavage of RasGAP that protects cells from apoptosis, whereas a stronger activation of caspases allows completion of RasGAP cleavage and the resulting RasGAP fragments turn into potent proapoptotic molecules (Yang and Widmann, 2001, 2002) . Authors indicate that executioner caspases therefore control the extent of their own activation by a feedback regulatory mechanism initiated by the partial cleavage of RasGAP that is crucial for cell survival under adverse conditions (Yang et al. 2004) .
Although caspases are mainly localized in the cytosol, a fraction of them has been identified in cellular organelles, for example, procaspase-3 was identified in the mitochondria, in a complex with HSP60 and HSP10 (Zhivotovsky et al., 1999) , a substantial portion of procaspase-2 was localized to the nucleus and Golgi complex (Mancini et al., 2000) while procaspase-9 was identified in the nucleus . A localized activation of caspases could account for some nonapoptotic functions of these enzymes, for example, activated forms of caspase-3 detected in maturing megakaryocytes before proplatelet formation demonstrate a punctuate cytoplasmic distribution, whereas a diffuse staining pattern is observed in these cells when becoming apoptotic (De Botton et al., 2002) . A procaspase redistribution is associated with phorbol ester-induced differentiation of U937 monocytic leukemic cells (Sordet et al., 2001) , a model in which caspase activation is required for the differentiation process (Sordet et al., 2002) . Whether the differentiationassociated redistribution of the caspase inhibitor cIAP-1, which is present in the nucleus of undifferentiated cells and is relocalized to the Golgi apparatus in cells undergoing differentiation (Plenchette et al., 2004; Vischioni et al., 2004) , is involved in the control of caspase activation in some differentiation pathways remains unknown. However, another IAP, Dbruce, protects differentiating fly spermatids from destruction by caspases activated during the differentiation process (Arama et al., 2003) . At the level of death receptors, the role of molecule redistribution into plasma membrane rafts remains a controversial issue but the recruitment of regulatory molecules such as FLIP L at the level of the deathinducing signaling complex appears to modulate the level of caspase-8 activation and downstream signalization (Micheau et al., 2002; O'Reilly et al., 2004) . One could speculate that, in tumor cells, deregulated expression of regulatory molecules such as IAPs and FLIP, in addition to inhibiting cell death and inducing chemoresistance (Kim et al., 2001; Liu et al., 2002; Shin et al., 2002; Yang, 2002) , may favor nonlethal pathways of signalization that contribute to enhanced tumorigenesis (Barnhart et al., 2004) .
Analysis of nonlethal functions of caspases may clarify the role of enzymes such as of the evolutionarily conserved caspase-2 whose apoptotic functions appear to be limited to amplification of other caspase cascades (Droin et al., 2001) . Recent data suggest that caspase-2 could play a role in other cellular functions such as DNA repair (Tinel and Tschopp, 2004) and cellular lipid metabolism (unpublished results). After more than a decade of research dedicated to the study of apoptotic functions of caspases, several nonapoptotic functions of these enzymes have now been identified. It is likely that other biological functions of caspases are still to be uncovered. Ongoing studies may provide more informations of caspase targets associated with a specific cellular function and decipher the regulatory mechanisms that control the multiple functions of these versatile enzymes. They may also shed new lights on the role of caspase activity deregulation in the pathophysiology of various human diseases.
